L-CYSTEINE HCL H2O

We are L-CYSTEINE HCL H2O CAS:7048-04-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


L-CYSTEINE HCL H2O
 

Abbreviation	L-Cys HCl H2O
Chemical Name	(R)-2-Amino-3-mercaptopropionic Acid Monohydrochloride Monohydrate
Chemical Formula	C3H7NO2S·HCl·H2O
Molecular Weight	175.63
Nitrogen Content	7.97%
CAS Number	7048-04-6
Conforms To	USP, EP
Solubility	Very soluble in water
Assay	98.5 to 101.0%
Specification	White crystals or crystalline powder; strongly acid taste
Country of Origin	China
Manufacturing Process	Fermentation
Packaging	1 kg, 10 kg poly pail, 20kg fiber box
Additional Information	Cysteine HCl H2O is a non-essential amino acid. It is a precursor to taurine and a component of antioxidant glutathione. Improves hepatic function and used in amino acids infusions, as a flavoring component, bread fermentation supplement and as an antioxidant for natural fruit juice products. Cysteine HCl H2O is manufactured by adding hydrochloric acid to cysteine base.

 




Related News: “Administrative Measures for the Joint Review, Review and Approval of Raw Materials, Medicinal Auxiliaries and Pharmaceutical Packaging Materials and Pharmaceutical Preparations” (Consultation Draft) issued by the State Food and Drug Administration in December 2017. Supervision departments no longer accept applications for registration of APIs, pharmaceutical excipients, and packaging materials.fluoranthen-3-amine Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.4-Bromo-N,N-dimethylaniline With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.Ácido 3-amino-2-hidroxi-5-nitrobencenosulfónico CAS:96-67-3 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).